Filing Details

Accession Number:
0001209191-12-007604
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-02-03 18:05:18
Reporting Period:
2012-02-01
Filing Date:
2012-02-03
Accepted Time:
2012-02-03 18:05:18
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1103390 Ardea Biosciences Inc. RDEA Pharmaceutical Preparations (2834) 943200380
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1178579 C Kevin Tang 4747 Executive Drive
Suite 510
San Diego CA 92121
Yes No Yes No
1191935 Tang Capital Partners Lp 4747 Executive Drive
Suite 510
San Diego CA 92121
No No Yes No
1232621 Tang Capital Management Llc 4747 Executive Drive
Suite 510
San Diego CA 92121
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2012-02-01 426,470 $17.00 3,733,582 No 4 P Indirect By LP
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect By LP
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 67,052 Indirect As Trustee
Common Stock 15,089 Direct
Footnotes
  1. The securities are held by Tang Capital Partners, LP. Kevin C. Tang is the sole manager of Tang Capital Management, LLC, which is the general partner of Tang Capital Partners, LP. Mr. Tang disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.
  2. The securities are owned by Kevin C. Tang as custodian for his minor children and as Trustee of the Tang Advisors, LLC Profit Sharing Plan, for which Mr. Tang serves as Trustee and in which he is a participant. Mr. Tang disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.
  3. The securities are owned by Kevin C. Tang's IRA.